Article
Inorganic Chemistry, Vol. 48, No. 12, 2009 5115
Table 8. X-ray Structure Parameters for the Three- And Four-Coordinate Complexes Discussed in This Work
LtBu,iPr2Fe
(SPh)
LtBu,iPr2Fe
(SPhCF3)
LtBu,iPr2Fe
(STol)
LtBu,iPr2Fe
(OTol)
LtBu,iPr2Fe(SPh)
(CNtBu)
LtBu,iPr2Fe(SPh)
(MeIm) C6H6
LtBu,iPr2Fe(SPh)
(DMF)
3
empirical formula C41H58N2SFe C42H57N2F3SFe
fw
C42H60N2SFe C42H60N2OFe
680.83
193(2)
C46H67N3SSFe
749.94
100.0(1)
monoclinic
P21/n
10.693(9)
19.719(16)
21.014(17)
90
96.683(12)
90
4401(6)
4
1.132
C51H70N4SFe
827.02
100.0(1)
triclinic
P1
9.575(5)
12.487(5)
20.562(5)
79.982(5)
77.463(5)
88.120(5)
2363.2(17)
2
C44H65N3OSFe
739.9
100.0(1)
triclinic
P1
10.3921(12)
12.4143(14)
17.392(2)
102.907(2)
99.220(2)
94.130(2)
2145.2(4)
2
666.8
193(2)
734.81
193(2)
664.77
193(2)
temperature (K)
cryst system
space group
monoclinic
P21/n
10.8405(15)
16.368(2)
21.579(3)
monoclinic
P21/c
22.1226(10)
9.6586(4)
20.9138(9)
monoclinic
P21/c
monoclinic
P21/c
˚
a (A)
22.1137(11)
9.6346(5)
20.4372(10)
22.0892(14)
9.6154(6)
20.5038(13)
˚
b (A)
˚
c (A)
β (deg)
91.007(2)
114.980(1)
114.858(1)
115.819(1)
3
V (A )
˚
3828.3(9)
4
4050.7(3)
4
3950.9(3)
4
3920.2(4)
4
Z
F (g/cm3)
1.157
0.477
0.0420
0.1012
1.017
1.205
0.468
0.0344
0.0946
1.087
1.145
0.464
0.0377
0.0897
1.039
1.126
0.147
0.0534
0.1114
1.058
1.162
0.400
0.0562
0.1016
0.975
1.145
0.434
0.0431
0.0949
1.010
μ (mm-1
R1
)
0.423
0.0489
0.1113
1.018
wR2 [I >2σ(I)]
GOF
1624(w), 1577 (w), 1502 (m), 1473 (w), 1459 (w), 1430 (s),
1375 (m), 1354 (s), 1317 (m), 1217 (w), 1096 (w), 1024 (w),
780 (w), 736 (m), 697 (w) cm-1 Anal. Calcd for C41H58-
N2SFe: C, 73.84; H, 8.76; N, 4.20%. Found: C, 74.20; H, 9.01;
N, 4.27%.
LtBu,iPr2Fe(STol). Yield 75%. 1H NMR (C6D6, 500 MHz):
δ 87 (1H, R-H), 54 (2H, o-STol), 50 (2H, m-STol), 45
(3H, CH3-STol), 40 (18H, tBu), 5.9 (4H, m-Ar), -24 (12H,
iPr methyl), -99 (4H, iPr methine), -111 (12H, iPr methyl),
-114 (2H, p-Ar) ppm. UV-vis (Tol.) λmax: 553 nm (45(2) M-1
cm-1). IR (KBr, cm-1): 2963 (s), 2867 (m), 1624 (m), 1535 (w),
1503 (m), 1485 (m), 1458 (m), 1430 (m), 1375 (m), 1355 (s), 1316
(m), 1218 (w), 1108 (w), 1087 (m), 932 (w), 805 (m), 762 (m).
Anal. Calcd for C42H60N2SFe: C, 74.09; H, 8.88; N, 4.11%.
Found: C, 73.78; H, 8.84; N, 4.04%.
LtBu,iPr2Fe(SPhCF3). Yield 85%. 1H NMR (C6D6,
500 MHz): δ 84 (1H, R-H), 54 (2H, o-SPh), 49 (2H, m-SPh),
40 (18H, tBu), 7.9 (4H, m-Ar), -24 (12H, iPr methyl), -98 (4H,
iPr methine), -111 (12H, iPr methyl), -118 (2H, p-Ar) ppm. μeff
(Evans, C6D6): 4.9(5) μB. UV-vis (Tol) λmax: 563 nm (42(2) M-1
cm-1). IR (KBr cm-1): 2964 (s), 2873 (w), 1600 (m), 1503 (m),
1353 (s), 1323 (vs), 1158 (m), 1116 (m), 1091 (m), 1062 (w),
1014 (w), 827 (w), 800 (w), 781 (w). Anal. Calcd for
C42H57N2SFe: C, 68.64; H, 7.82; N, 3.81%. Found: C, 68.37;
H, 8.09; N, 3.80%.
LtBu,iPr2Fe(OPh). Yield 78%. 1H NMR (C6D6, 500 MHz):
δ 119 (1H, R-H), 94 (2H, o-OPh), 60 (2H, m-OPh), 42 (18H,
tBu), -4.4 (4H, m-Ar), -7.2 (1H, p-OPh), -30 (12H, iPr
methyl), -103 (2H, p-Ar), -118 (4H, iPr methine, 12H, iPr
LtBu,iPr2Fe(SPh)(CNtBu). In a 20 mL scintillation vial,
CNtBu (70 μL, 0.619 mmol) was added via syringe to a red-
orange solution of LtBu,iPr2Fe(SPh) (81.0 mg, 0.122 mmol) in
Et2O (8 mL). The solution was cooled to -35 °C overnight to
give orange crystals (67.8 mg, 75%). 1H NMR (C6D6, 500
MHz): δ 33, 27, 25, 20, 13, 8.1, 4.0, 2.1, 1.2, 0.29, -4.4, -4.9,
-17, -50 ppm. IR (KBr): 3057 (w), 2962 (vs), 2868 (m), 2168 (s),
2127 (m), 1618 (m), 1491 (m), 1473 (m), 1465 (w), 1431 (m), 1352
(s), 1315 (s), 1254 (w), 1215 (m), 1153 (w), 1105 (w), 1024 (w),
933 (w), 887 (w), 795 (w), 762 (w), 739 (w), 692 (w) cm-1. Anal.
Calcd for C46H67N3SFe: C, 73.67; H, 9.00; N, 5.60%. Found:
C, 72.87; H, 9.01; N, 5.58%.
LtBu,iPr2Fe(SPh)(DMF). In a 20 mL scintillation vial,
DMF (94 μL, 1.21 mmol) was added via syringe to a red-orange
solution of LtBu,iPr2Fe(SPh) (81.8 mg, 0.123 mmol) in Et2O
(10 mL). Upon swirling the solution orange crystals began to
form. Cooling to -35 °C gave orange crystals in two crops
(84.5 mg, 93%). Anal. Calcd for C45H67N3OSFe: C, 71.42; H,
8.85; N, 5.68%. Found: C, 70.66; H, 8.71; N, 5.46%. IR (KBr):
3063(w), 2968 (vs), 2868 (m), 1651 (vs), 1578 (m), 1527 (w), 1487
(m), 1460 (s), 1431 (s), 1383 (s), 1360 (s), 1315 (m), 1251 (w), 1217
(w), 1184 (w), 1153 (w), 1109 (m), 1063 (w), 1024 (w), 933 (w),
1
885 (w), 794 (w), 764 (m), 739 (m) 692 (m) cm-1. H NMR
(C6D6, 500 MHz): δ 33, 18.0, 17.6, 5.8, 1.4, 1.2, -3.9, -20, -34,
-67 ppm.
LtBu,iPr2Fe(SPh)(MeIm). In a 20 mL scintillation vial,
N-methylimidazole (20 μL, 0.251 mmol) was added dropwise
via syringe to a red-orange solution of LtBu,iPr2Fe(SPh) (80.8 mg,
0.121 mmol) in Et2O (10 mL). Upon swirling the solution, an
orange solid precipitated immediately. Placing in the freezer
(-35 °C) overnight gave a fluffy orange solid (81.7 mg, 90%).
This complex can be crystallized from benzene. 1H NMR
(C6D6, 500 MHz): δ 49, 27, 23, 22, 12, 1.2, 2.0, 5.6, 20, 28, 48,
89 ppm. IR (KBr): 3110 (w), 2966 (s), 2866 (m), 1578 (m), 1533
(m), 1489 (s), 1466 (m), 1433 (m), 1379 (s), 1356 (vs), 1315 (s),
1284 (w), 1252 (w), 1217 (m), 1186 (w), 1153 (w), 1099 (m), 1022
(w), 939 (w), 779 (w), 742 (m) cm-1. Anal. Calcd for
C45H64N4SFe: C, 72.17; H, 8.61; N, 7.46%. Found: C, 72.82;
H, 8.71; N, 6.93%.
methyl) ppm. μeff (Evans, C6D6): 5.6(5) μB. UV-vis (Tol) λmax
:
533 nm (56(3) M-1 cm-1). IR (KBr cm-1): 2959 (s), 2867 (w),
1588 (m), 1490 (s), 1430 (w), 1376 (m), 1359 (s), 1318 (m), 1294
(m), 1217 (w), 1180 (w), 1096 (w), 871 (w), 802 (w), 755 (m),
691 (w). Anal. Calcd for C41H58N2OFe: C, 75.67; H, 8.98;
N, 4.30%. Found: C, 75.29; H, 8.90; N, 4.08%.
LtBu,iPr2Fe(OTol). Yield 75%. 1H NMR (C6D6, 400 MHz):
δ 117 (1H, R-H), 94 (2H, o-OTol), 83 (3H, CH3-OTol), 55 (2H,
m-OTol), 41 (18H, tBu), -4.1 (4H, m-Ar), -29 (12H, iPr
methyl), -101 (2H, p-Ar), -115 (4H, iPr methine, 12H, iPr
methyl) ppm. UV-vis (Et2O) λmax: 531 nm (79(4) M-1 cm-1).
IR (KBr cm-1): 2963 (s), 2870 (w), 1618 (w), 1502 (s), 1459 (w),
1430 (w), 1360 (s), 1319 (m), 1280 (m), 1105 (w), 934 (w), 873 (w),
821 (m), 779 (w), 762 (m). Anal. Calcd for C42H60N2OFe: C,
75.88; H, 9.09; N, 4.21%. Found: C, 74.83; H, 9.13; N, 4.22%.
This compound is somewhat unstable in solution, depositing a
solid over time. Therefore, its purity is suspect, consistent with
the elemental analysis data.
UV-vis Equilibrium Experiments. Three-coordinate iron
complexes were dissolved in toluene and filtered through a plug
of Celite before adding any reagent(s). Fitting used Kaleida-
Graph 3.6.2 (Synergy Software). For weak binding, the plot of
[L]0 versus ΔAλmax was fit to eq 3 with refinement of the binding
constant Keq and a scaling factor. For strong binding, the plot of
[L]0 versus ΔAλmax was fit to eq 4 with refinement of [M]0, Keq,
and a scaling factor. It was necessary to refine [M]0 because the
quality of the fit was drastically affected by small variations in